C-αντιδρώσα πρωτεΐνη (Greek Wikipedia)

Analysis of information sources in references of the Wikipedia article "C-αντιδρώσα πρωτεΐνη" in Greek language version.

refsWebsite

Global rank Greek rank

4^th place

4^th place

2^nd place

3^rd place

6^th place

5^th place

3web.archive.org

1^st place

1^st place

1books.google.com

3^rd place

6^th place

1wisconsinmedicalsociety.org

low place

9,682^nd place

low place

low place

low place

low place

14^th place

37^th place

18^th place

57^th place

low place

2,967^th place

annals.org

«Narrative review: Assessment of C-reactive protein in risk prediction for cardiovascular disease». Annals of Internal Medicine 145 (1): 35–42. July 2006. doi:10.7326/0003-4819-145-1-200607040-00129. PMID 16818927. Αρχειοθετήθηκε από το πρωτότυπο στις 2008-04-17. https://web.archive.org/web/20080417140838/http://www.annals.org/cgi/content/full/0000605-200607040-00129v1. Ανακτήθηκε στις 2008-05-01.

archive.org

«C-reactive protein: a critical update». The Journal of Clinical Investigation 111 (12): 1805–12. June 2003. doi:10.1172/JCI18921. PMID 12813013. PMC 161431. https://archive.org/details/sim_journal-of-clinical-investigation_2003-06_111_12/page/1805.
Kennelly PJ, Murray RF, Rodwell VW, Botham KM (2009). Harper's illustrated biochemistry. McGraw-Hill Medical. ISBN 978-0-07-162591-3.
Pincus MR, McPherson RA, Henry JB (2007). Henry's clinical diagnosis and management by laboratory methods. Saunders Elsevier. ISBN 978-1-4160-0287-1.
«Genetic variation, C-reactive protein levels, and incidence of diabetes». Diabetes 56 (3): 872–8. March 2007. doi:10.2337/db06-0922. PMID 17327459. https://archive.org/details/sim_diabetes_2007-03_56_3/page/872.
«Consumption of trans fatty acids is related to plasma biomarkers of inflammation and endothelial dysfunction». The Journal of Nutrition 135 (3): 562–6. March 2005. doi:10.1093/jn/135.3.562. PMID 15735094. https://archive.org/details/sim_journal-of-nutrition_2005-03_135_3/page/562.
«Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive C-reactive protein levels». Circulation 103 (15): 1933–5. April 2001. doi:10.1161/01.CIR.103.15.1933. PMID 11306519. https://archive.org/details/sim_circulation_2001-04-17_103_15/page/n26.
«Exercise intervention and inflammatory markers in coronary artery disease: a meta-analysis». American Heart Journal 163 (4): 666–76.e1–3. April 2012. doi:10.1016/j.ahj.2011.12.017. PMID 22520533. https://archive.org/details/sim_american-heart-journal_2012-04_163_4/page/666.
Goldman L (2011). Goldman's Cecil Medicine (24th έκδοση). Philadelphia: Elsevier Saunders. σελίδες 54. ISBN 978-1437727883.
«Preliminary case-control study to evaluate diagnostic values of C-reactive protein and erythrocyte sedimentation rate in differentiating active Crohn's disease from intestinal lymphoma, intestinal tuberculosis and Behcet's syndrome». The American Journal of the Medical Sciences 346 (6): 467–72. December 2013. doi:10.1097/MAJ.0b013e3182959a18. PMID 23689052. https://archive.org/details/sim_american-journal-of-the-medical-sciences_2013-12_346_6/page/467. ^{[Αναξιόπιστη πηγή]}

archive.today

Koenig, Wolfgang (2006). "C-reactive protein - a critical cardiovascular risk marker" Αρχειοθετήθηκε 2012-07-23 at Archive.is. CRPhealth.com.

books.google.com

Ananthanarayan R, Paniker CJ (1978). Ananthanarayan and Paniker's Textbook of Microbiology (7th έκδοση). Himayatnagar, Hyderabad: Orient Longman. σελ. 218. ISBN 9788125028086.

crphealth.com

Koenig, Wolfgang (2006). "C-reactive protein - a critical cardiovascular risk marker" Αρχειοθετήθηκε 2012-07-23 at Archive.is. CRPhealth.com.

doi.org

dx.doi.org

«The physiological structure of human C-reactive protein and its complex with phosphocholine». Structure 7 (2): 169–77. February 1999. doi:10.1016/S0969-2126(99)80023-9. PMID 10368284.
«C-reactive protein: a critical update». The Journal of Clinical Investigation 111 (12): 1805–12. June 2003. doi:10.1172/JCI18921. PMID 12813013. PMC 161431. https://archive.org/details/sim_journal-of-clinical-investigation_2003-06_111_12/page/1805.
«Adipokines: molecular links between obesity and atheroslcerosis». American Journal of Physiology. Heart and Circulatory Physiology 288 (5): H2031–41. May 2005. doi:10.1152/ajpheart.01058.2004. PMID 15653761.
«Serological reactions in pneumonia with a nonprotein somatic fraction of pneumococcus». The Journal of Experimental Medicine 52 (4): 561–71. September 1930. doi:10.1084/jem.52.4.561. PMID 19869788.
«C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus». JAMA 286 (3): 327–34. July 2001. doi:10.1001/jama.286.3.327. PMID 11466099.
«Genetic variation, C-reactive protein levels, and incidence of diabetes». Diabetes 56 (3): 872–8. March 2007. doi:10.2337/db06-0922. PMID 17327459. https://archive.org/details/sim_diabetes_2007-03_56_3/page/872.
«Consumption of trans fatty acids is related to plasma biomarkers of inflammation and endothelial dysfunction». The Journal of Nutrition 135 (3): 562–6. March 2005. doi:10.1093/jn/135.3.562. PMID 15735094. https://archive.org/details/sim_journal-of-nutrition_2005-03_135_3/page/562.
«C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease». The New England Journal of Medicine 350 (14): 1387–97. April 2004. doi:10.1056/NEJMoa032804. PMID 15070788.
«Targeting C-reactive protein for the treatment of cardiovascular disease». Nature 440 (7088): 1217–21. April 2006. doi:10.1038/nature04672. PMID 16642000. Bibcode: 2006Natur.440.1217P.
«Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein». The New England Journal of Medicine 359 (21): 2195–207. November 2008. doi:10.1056/NEJMoa0807646. PMID 18997196.
«Effects of atorvastatin and rosuvastatin on high-sensitivity C-reactive protein and lipid profile in obese type 2 diabetes mellitus patients». Journal of Pharmacology & Pharmacotherapeutics 2 (4): 261–5. October 2011. doi:10.4103/0976-500X.85954. PMID 22025854.
«Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive C-reactive protein levels». Circulation 103 (15): 1933–5. April 2001. doi:10.1161/01.CIR.103.15.1933. PMID 11306519. https://archive.org/details/sim_circulation_2001-04-17_103_15/page/n26.
«C-reactive protein concentration and the vascular benefits of statin therapy: an analysis of 20,536 patients in the Heart Protection Study». Lancet 377 (9764): 469–76. February 2011. doi:10.1016/S0140-6736(10)62174-5. PMID 21277016.
«Exercise intervention and inflammatory markers in coronary artery disease: a meta-analysis». American Heart Journal 163 (4): 666–76.e1–3. April 2012. doi:10.1016/j.ahj.2011.12.017. PMID 22520533. https://archive.org/details/sim_american-heart-journal_2012-04_163_4/page/666.
«Narrative review: Assessment of C-reactive protein in risk prediction for cardiovascular disease». Annals of Internal Medicine 145 (1): 35–42. July 2006. doi:10.7326/0003-4819-145-1-200607040-00129. PMID 16818927. Αρχειοθετήθηκε από το πρωτότυπο στις 2008-04-17. https://web.archive.org/web/20080417140838/http://www.annals.org/cgi/content/full/0000605-200607040-00129v1. Ανακτήθηκε στις 2008-05-01.
«Within-person variability in high-sensitivity C-reactive protein». Archives of Internal Medicine 172 (19): 1519–21. October 2012. doi:10.1001/archinternmed.2012.3712. PMID 22945505.
«Inflammation, a key event in cancer development». Molecular Cancer Research 4 (4): 221–33. April 2006. doi:10.1158/1541-7786.MCR-05-0261. PMID 16603636.
«Interferon-alpha mediates suppression of C-reactive protein: explanation for muted C-reactive protein response in lupus flares?». Arthritis and Rheumatism 60 (12): 3755–60. December 2009. doi:10.1002/art.25042. PMID 19950271.
«What's new in Emergencies Trauma and Shock? C-reactive protein as a potential clinical biomarker for influenza infection: More questions than answers». Journal of Emergencies, Trauma, and Shock 5 (2): 115–7. April 2012. doi:10.4103/0974-2700.96477. PMID 22787338.
«Preliminary case-control study to evaluate diagnostic values of C-reactive protein and erythrocyte sedimentation rate in differentiating active Crohn's disease from intestinal lymphoma, intestinal tuberculosis and Behcet's syndrome». The American Journal of the Medical Sciences 346 (6): 467–72. December 2013. doi:10.1097/MAJ.0b013e3182959a18. PMID 23689052. https://archive.org/details/sim_american-journal-of-the-medical-sciences_2013-12_346_6/page/467. ^{[Αναξιόπιστη πηγή]}

harvard.edu

adsabs.harvard.edu

«Targeting C-reactive protein for the treatment of cardiovascular disease». Nature 440 (7088): 1217–21. April 2006. doi:10.1038/nature04672. PMID 16642000. Bibcode: 2006Natur.440.1217P.

jaoa.org

«C-reactive protein: a new risk assessment tool for cardiovascular disease». The Journal of the American Osteopathic Association 105 (9): 409–16. September 2005. PMID 16239491. Αρχειοθετήθηκε από το πρωτότυπο στις 2012-01-10. https://web.archive.org/web/20120110071000/http://www.jaoa.org/content/105/9/409.full. Ανακτήθηκε στις 2013-02-10.

nih.gov

ncbi.nlm.nih.gov

«The physiological structure of human C-reactive protein and its complex with phosphocholine». Structure 7 (2): 169–77. February 1999. doi:10.1016/S0969-2126(99)80023-9. PMID 10368284.
«C-reactive protein: a critical update». The Journal of Clinical Investigation 111 (12): 1805–12. June 2003. doi:10.1172/JCI18921. PMID 12813013. PMC 161431. https://archive.org/details/sim_journal-of-clinical-investigation_2003-06_111_12/page/1805.
«Adipokines: molecular links between obesity and atheroslcerosis». American Journal of Physiology. Heart and Circulatory Physiology 288 (5): H2031–41. May 2005. doi:10.1152/ajpheart.01058.2004. PMID 15653761.
«Serological reactions in pneumonia with a nonprotein somatic fraction of pneumococcus». The Journal of Experimental Medicine 52 (4): 561–71. September 1930. doi:10.1084/jem.52.4.561. PMID 19869788.
«CRP C-reactive protein [Homo sapiens]». Entrez Gene. National Center for Biotechnology Information (NCBI), U.S. National Library of Medicine.
«#CAA39671». NCBI Entrez Protein.
«Erythrocyte Sedimentation Rate and C-reactive Protein Measurements and Their Relevance in Clinical Medicine». Wisconsin Medical Journal (WMJ) 115 (6): 317–21. December 2016. PMID 29094869. Αρχειοθετήθηκε από το πρωτότυπο στις 2018-02-18. https://web.archive.org/web/20180218150632/http://www.wisconsinmedicalsociety.org/_WMS/publications/wmj/pdf/115/6/317.pdf. Ανακτήθηκε στις 2019-08-04.
«C-reactive protein: a new risk assessment tool for cardiovascular disease». The Journal of the American Osteopathic Association 105 (9): 409–16. September 2005. PMID 16239491. Αρχειοθετήθηκε από το πρωτότυπο στις 2012-01-10. https://web.archive.org/web/20120110071000/http://www.jaoa.org/content/105/9/409.full. Ανακτήθηκε στις 2013-02-10.
«C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus». JAMA 286 (3): 327–34. July 2001. doi:10.1001/jama.286.3.327. PMID 11466099.
«Genetic variation, C-reactive protein levels, and incidence of diabetes». Diabetes 56 (3): 872–8. March 2007. doi:10.2337/db06-0922. PMID 17327459. https://archive.org/details/sim_diabetes_2007-03_56_3/page/872.
«Consumption of trans fatty acids is related to plasma biomarkers of inflammation and endothelial dysfunction». The Journal of Nutrition 135 (3): 562–6. March 2005. doi:10.1093/jn/135.3.562. PMID 15735094. https://archive.org/details/sim_journal-of-nutrition_2005-03_135_3/page/562.
«C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease». The New England Journal of Medicine 350 (14): 1387–97. April 2004. doi:10.1056/NEJMoa032804. PMID 15070788.
«Targeting C-reactive protein for the treatment of cardiovascular disease». Nature 440 (7088): 1217–21. April 2006. doi:10.1038/nature04672. PMID 16642000. Bibcode: 2006Natur.440.1217P.
«Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein». The New England Journal of Medicine 359 (21): 2195–207. November 2008. doi:10.1056/NEJMoa0807646. PMID 18997196.
«Effects of atorvastatin and rosuvastatin on high-sensitivity C-reactive protein and lipid profile in obese type 2 diabetes mellitus patients». Journal of Pharmacology & Pharmacotherapeutics 2 (4): 261–5. October 2011. doi:10.4103/0976-500X.85954. PMID 22025854.
«Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive C-reactive protein levels». Circulation 103 (15): 1933–5. April 2001. doi:10.1161/01.CIR.103.15.1933. PMID 11306519. https://archive.org/details/sim_circulation_2001-04-17_103_15/page/n26.
«C-reactive protein concentration and the vascular benefits of statin therapy: an analysis of 20,536 patients in the Heart Protection Study». Lancet 377 (9764): 469–76. February 2011. doi:10.1016/S0140-6736(10)62174-5. PMID 21277016.
«Exercise intervention and inflammatory markers in coronary artery disease: a meta-analysis». American Heart Journal 163 (4): 666–76.e1–3. April 2012. doi:10.1016/j.ahj.2011.12.017. PMID 22520533. https://archive.org/details/sim_american-heart-journal_2012-04_163_4/page/666.
«Narrative review: Assessment of C-reactive protein in risk prediction for cardiovascular disease». Annals of Internal Medicine 145 (1): 35–42. July 2006. doi:10.7326/0003-4819-145-1-200607040-00129. PMID 16818927. Αρχειοθετήθηκε από το πρωτότυπο στις 2008-04-17. https://web.archive.org/web/20080417140838/http://www.annals.org/cgi/content/full/0000605-200607040-00129v1. Ανακτήθηκε στις 2008-05-01.
«Within-person variability in high-sensitivity C-reactive protein». Archives of Internal Medicine 172 (19): 1519–21. October 2012. doi:10.1001/archinternmed.2012.3712. PMID 22945505.
«Inflammation, a key event in cancer development». Molecular Cancer Research 4 (4): 221–33. April 2006. doi:10.1158/1541-7786.MCR-05-0261. PMID 16603636.
«Interferon-alpha mediates suppression of C-reactive protein: explanation for muted C-reactive protein response in lupus flares?». Arthritis and Rheumatism 60 (12): 3755–60. December 2009. doi:10.1002/art.25042. PMID 19950271.
«What's new in Emergencies Trauma and Shock? C-reactive protein as a potential clinical biomarker for influenza infection: More questions than answers». Journal of Emergencies, Trauma, and Shock 5 (2): 115–7. April 2012. doi:10.4103/0974-2700.96477. PMID 22787338.
«Preliminary case-control study to evaluate diagnostic values of C-reactive protein and erythrocyte sedimentation rate in differentiating active Crohn's disease from intestinal lymphoma, intestinal tuberculosis and Behcet's syndrome». The American Journal of the Medical Sciences 346 (6): 467–72. December 2013. doi:10.1097/MAJ.0b013e3182959a18. PMID 23689052. https://archive.org/details/sim_american-journal-of-the-medical-sciences_2013-12_346_6/page/467. ^{[Αναξιόπιστη πηγή]}

pubmedcentral.nih.gov

«C-reactive protein: a critical update». The Journal of Clinical Investigation 111 (12): 1805–12. June 2003. doi:10.1172/JCI18921. PMID 12813013. PMC 161431. https://archive.org/details/sim_journal-of-clinical-investigation_2003-06_111_12/page/1805.
«Serological reactions in pneumonia with a nonprotein somatic fraction of pneumococcus». The Journal of Experimental Medicine 52 (4): 561–71. September 1930. doi:10.1084/jem.52.4.561. PMID 19869788.
«Effects of atorvastatin and rosuvastatin on high-sensitivity C-reactive protein and lipid profile in obese type 2 diabetes mellitus patients». Journal of Pharmacology & Pharmacotherapeutics 2 (4): 261–5. October 2011. doi:10.4103/0976-500X.85954. PMID 22025854.
«C-reactive protein concentration and the vascular benefits of statin therapy: an analysis of 20,536 patients in the Heart Protection Study». Lancet 377 (9764): 469–76. February 2011. doi:10.1016/S0140-6736(10)62174-5. PMID 21277016.
«Within-person variability in high-sensitivity C-reactive protein». Archives of Internal Medicine 172 (19): 1519–21. October 2012. doi:10.1001/archinternmed.2012.3712. PMID 22945505.
«What's new in Emergencies Trauma and Shock? C-reactive protein as a potential clinical biomarker for influenza infection: More questions than answers». Journal of Emergencies, Trauma, and Shock 5 (2): 115–7. April 2012. doi:10.4103/0974-2700.96477. PMID 22787338.

web.archive.org

«Erythrocyte Sedimentation Rate and C-reactive Protein Measurements and Their Relevance in Clinical Medicine». Wisconsin Medical Journal (WMJ) 115 (6): 317–21. December 2016. PMID 29094869. Αρχειοθετήθηκε από το πρωτότυπο στις 2018-02-18. https://web.archive.org/web/20180218150632/http://www.wisconsinmedicalsociety.org/_WMS/publications/wmj/pdf/115/6/317.pdf. Ανακτήθηκε στις 2019-08-04.
«C-reactive protein: a new risk assessment tool for cardiovascular disease». The Journal of the American Osteopathic Association 105 (9): 409–16. September 2005. PMID 16239491. Αρχειοθετήθηκε από το πρωτότυπο στις 2012-01-10. https://web.archive.org/web/20120110071000/http://www.jaoa.org/content/105/9/409.full. Ανακτήθηκε στις 2013-02-10.
«Narrative review: Assessment of C-reactive protein in risk prediction for cardiovascular disease». Annals of Internal Medicine 145 (1): 35–42. July 2006. doi:10.7326/0003-4819-145-1-200607040-00129. PMID 16818927. Αρχειοθετήθηκε από το πρωτότυπο στις 2008-04-17. https://web.archive.org/web/20080417140838/http://www.annals.org/cgi/content/full/0000605-200607040-00129v1. Ανακτήθηκε στις 2008-05-01.

wisconsinmedicalsociety.org

«Erythrocyte Sedimentation Rate and C-reactive Protein Measurements and Their Relevance in Clinical Medicine». Wisconsin Medical Journal (WMJ) 115 (6): 317–21. December 2016. PMID 29094869. Αρχειοθετήθηκε από το πρωτότυπο στις 2018-02-18. https://web.archive.org/web/20180218150632/http://www.wisconsinmedicalsociety.org/_WMS/publications/wmj/pdf/115/6/317.pdf. Ανακτήθηκε στις 2019-08-04.